Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical trial (NCT05654623) evaluating vepdegestrant monotherapy versus ...

We think it can be appropriate to present phase 2 trial participation as offering a small prospect of benefit,” researchers wrote. About 16% of patients enrolled in phase 2 cancer trials receive a ...

Proportion increases when considering off-label use but drops when considering drugs with substantial clinical benefit.

This trial, supported by the Cancer Prevention Clinical Trials ... scope and results of clinical trials, including the anticipated Phase 3 study for amezalpat; anticipated therapeutic benefit ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

US-based pharmaceutical company AbbVie has reported the final analysis from the Phase III MIRASOL trial, which assessed its ...

First patient enrolled in ECLIPSE 1 Phase 3 clinical trial evaluating combination of ... in the U.S. facing an uncertain future without approved treatment options,” said Chari A.

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Sanofi is banking on the totality of data from the three phase 3 trials supporting potential ... from regulators – it files the drug for approval in MS. The drug is one of several oral BTK ...

“FDA approval of our forthcoming U.S. trials in patients with newly diagnosed pancreatic cancer and our investigator-initiated ... NH facility expected to complete its first phase of construction in ...

Clinical trial ... cancer using RNA therapeutics, today announced that the Safety Review Committee (SRC) monitoring its Phase I clinical trial has unanimously approved opening of the fourth cohort of ...